AI assistant
INSMED Inc — Director's Dealing 2024
Jan 2, 2024
30150_dirs_2024-01-02_0202ec02-a818-4aa5-84fe-600ce0a1cbb3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2023-12-28
Reporting Person: Schaeffer Orlov S Nicole (Chief People Strategy Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-12-28 | Common Stock | M | 22288 | $20.49 | Acquired | 116837 | Direct |
| 2023-12-28 | Common Stock | S | 22288 | $32 | Disposed | 94549 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-12-28 | Stock Option (right to buy) | $20.49 | M | 22288 | Disposed | 2024-01-04 | Common Stock (22288) | Direct |
Footnotes
F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2: Includes 1,024 shares acquired through the Company's 2018 Employee Stock Purchase Plan.
F3: Stock options granted under the Company's 2013 Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.